title: Subcutaneous implantable cardioverter-defibrillator and drug-induced Brugada syndrome: the importance of repeat morphology analysis during ajmaline challenge.
authors.affiliation: Cardiocentro Ticino, Lugano, Switzerland giulio.conte@cardiocentro.org.
authors.forename: Giulio
authors.initials: G
authors.lastname: Conte
authors.affiliation: Cardiocentro Ticino, Lugano, Switzerland.
authors.forename: Francois
authors.initials: F
authors.lastname: Regoli
authors.affiliation: Cardiocentro Ticino, Lugano, Switzerland.
authors.forename: Tiziano
authors.initials: T
authors.lastname: Moccetti
authors.affiliation: Cardiocentro Ticino, Lugano, Switzerland.
authors.forename: Angelo
authors.initials: A
authors.lastname: Auricchio
mesh_terms: D000368:Aged; D000404:Ajmaline / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D053840:Brugada Syndrome / Q000139:chemically induced*; D017147:Defibrillators, Implantable; D004562:Electrocardiography; D005260:Female; D006323:Heart Arrest / Q000209:etiology*; D006801:Humans; D056888:Patient Positioning; D014693:Ventricular Fibrillation / Q000188:drug therapy
chemical_list: D000889:Anti-Arrhythmia Agents; D000404:Ajmaline